Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jeffrey Kenneth Vogel currently holds 506,934 shares of BIOSPECIFICS TECHNOLOGIES CORP (BSTC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey Kenneth Vogel has been a net seller of BSTC stock. They have purchased $3.6M and sold $5.7M worth of shares.
Jeffrey Kenneth Vogel's most recent insider trade was on Nov 25, 2015, when they purchased 2,000 shares at $48.20 per share.
Jeffrey Kenneth Vogel serves as Executive at BIOSPECIFICS TECHNOLOGIES CORP (BSTC). They have executed 180 insider transactions totaling $9.2M over their tenure at the company.
Jeffrey Kenneth Vogel holds the position of Executive at BIOSPECIFICS TECHNOLOGIES CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Jeffrey Kenneth Vogel has shown a selling trading pattern, with $3.6M in total purchases and $5.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jeffrey Kenneth Vogel was on Jun 4, 2014, when they sold $578.5K worth of BSTC shares. This transaction involved 21,417 shares at $27.01 per share.
Jeffrey Kenneth Vogel currently owns 506,934 shares of BIOSPECIFICS TECHNOLOGIES CORP (BSTC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jeffrey Kenneth Vogel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jeffrey Kenneth Vogel has 180 Form 4 filings on record as an insider at BIOSPECIFICS TECHNOLOGIES CORP.
Set alerts for Jeffrey Kenneth Vogel and 40,000+ other insiders.